FDA approves Altaviva device for urge urinary incontinence The Altaviva device offers a minimally invasive treatment for urge urinary incontinence, with patients returning home with therapy activated It features a 15-year battery lifespan, MRI compatibility, and a 30-minute recharging time, enhancing patient convenience
Altaviva™ Tibial Nerve Implant for Urge Urinary Incontinence | Bladder . . . The Medtronic Altaviva™ implant is a small device placed under the skin near the ankle to gently stimulate the tibial nerve —a key pathway that helps the bladder and brain “talk” to each other It’s designed to reduce sudden urges and leaks from overactive bladder (OAB)
First patient treated with Medtronic Altaviva device A patient living with bladder control symptoms became the first to receive the commercially available Altaviva device from Medtronic, a minimally invasive, implantable tibial neuromodulation (ITNM) therapy to treat urge urinary incontinence
Patient Guide for the Altaviva System P The Medtronic Altaviva system is indicated for treatment of urge urinary incontinence (UUI) in patients who failed or could not tolerate more conservative treatments
Medtronic Wins FDA Approval for Altaviva Neuromodulation Device Medtronic has received U S Food and Drug Administration (FDA) approval for its Altaviva device, a minimally invasive implantable tibial neuromodulation therapy designed to treat urge urinary incontinence